Stockreport

Eledon Pharmaceuticals to Participate in January 2022 Investor Conferences

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF IRVINE, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company co [Read more]